Japanese Encephalitis
📧 Sign up to get email alerts when something new happens for Japanese Encephalitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 [Phase 3]
Phase 3 trial update assessing long-term persistence and the effect of a booster dose of the IC51 Japanese encephalitis vaccine, sponsored b…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population [Phase 3]
Phase 3 clinical trial update evaluating safety and immunogenicity of the Japanese Encephalitis vaccine IC51 (IXIARO) in a pediatric populat…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine [Phase 4]
Phase 4 study evaluating the immunogenicity and safety of a combined live attenuated varicella vaccine with a live attenuated Japanese encep…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea [Phase 3]
Phase 3 clinical trial in Korea evaluating the immunogenicity and safety of the Vero cell-derived Japanese encephalitis vaccine has complete…
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51 [Phase 3]
Phase 3 trial comparing three batches of the Japanese Encephalitis vaccine IC51 has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling [Phase 3]
This Phase 3 trial update reports the immunogenicity of a commercial batch of the JEV IC51 Japanese encephalitis vaccine up to 24 months aft…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers [Phase 3]
Phase 3 trial comparing a Japanese encephalitis chimeric virus vaccine to the SA14-14-2 vaccine in infants and toddlers has completed with r…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children [Phase 4]
This Clinical Trial Update reports on the antibody response to a boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in children in…
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis [Phase 2]
Phase 2 study evaluating intravenous immunoglobulin for safety and efficacy in Japanese encephalitis has completed.
-
CLINICAL_TRIALS withdrawal · 2013-03-08Clinical Trial Update: Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination [Phase 1]
A Phase 1 clinical trial evaluating immune responses to the IXIARO Japanese Encephalitis vaccine (batch JEV09L37) before and after revaccina…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. [Phase 3]
A Phase 3 safety trial evaluated the ChimeriVax-JE vaccine for preventing Japanese encephalitis. The study has completed and results have be…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX [Phase 3]
Phase 3 trial assessing the safety and efficacy of two Japanese Encephalitis vaccines, ChimeriVax-JE and JE-VAX, has been completed with res…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine [Phase 2]
Phase 2 trial of the Live Attenuated ChimeriVax-JE vaccine for Japanese encephalitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Immunogenicity Study of the Japanese Encephalitis Vaccine IC51 [Phase 3]
Phase 3 immunogenicity update of the Japanese encephalitis vaccine IC51 completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: Safety and Tolerability of the Japanese Encephalitis Vaccine IC51 [Phase 3]
Phase 3 trial update on safety and tolerability of the Japanese Encephalitis vaccine IC51 (Valneva).
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 [Phase 3]
A Phase 3 trial compares three commercial batches of the IC51 Japanese Encephalitis vaccine; results from the completed study were posted.
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) [Phase 2]
Phase 2 trial of ChimeriVax-JE and STAMARIL vaccines completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age [Phase 2]
Phase 2 safety and efficacy study evaluating two Japanese encephalitis vaccines (ChimeriVax-JE and JE Inactivated Mouse Brain Vaccine) in ch…
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX [Phase 2]
A Phase 2 safety and efficacy trial comparing two Japanese encephalitis vaccines, ChimeriVax-JE and JE-VAX, has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 [Phase 3]
Phase 3 trial evaluating a booster dose of the IC51 Japanese encephalitis vaccine completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population [Phase 4]
Phase 4 study evaluating safety and immunogenicity of Ixiaro (IC51) in an elderly population has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis [Phase 3]
A Phase 3 trial evaluating Ixiaro as a booster following mouse-brain derived Japanese encephalitis vaccines has completed.
-
EMA guidance · 2011-05-27European Medicines Agency recommends revaccination for some travellers in need of protection with Ixiaro
EMA recommends revaccination with Ixiaro (japanese encephalitis vaccine) for certain travellers to maintain protection.
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults [Phase 2]
Phase 2 trial evaluating the safety and immunogenicity of the ChimeriVax-JE live attenuated vaccine in healthy adults; results were posted i…
-
CLINICAL_TRIALS research · 2010-07-16Clinical Trial Update: Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan
Clinical trial update describing the seroepidemiology of Japanese encephalitis virus infection in Hualien, Taiwan.